JAZZ
$129.44
Revenue | $957.32Mn |
Net Profits | $104.44Mn |
Net Profit Margins | 10.91% |
Jazz Pharmaceuticals Plc’s revenue jumped 2.62% since last year same period to $957.32Mn in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 7.22% jump in its revenue since last 3-months.
Jazz Pharmaceuticals Plc’s net profit jumped 201.28% since last year same period to $104.44Mn in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 50.44% jump in its net profits since last 3-months.
Jazz Pharmaceuticals Plc’s net profit margin jumped 193.59% since last year same period to 10.91% in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 40.31% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 4.54 |
EPS Estimate Current Year | 4.54 |
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 4.54 - a -1.52% fall from last quarter’s estimates.
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 4.54.
Earning Per Share (EPS) | 0 |
Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Jazz Pharmaceuticals Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-10 | 4.25 | 0 | -100% |
2023-11-07 | 4.54 | 0 | -100% |
2023-08-09 | 4.61 | 0 | -100% |